One of the CPVT-related mutations, K206N, leads to an additional N-linked glycosylation site on Casq, which inhibits proper dimer formation in solution [20] and is expected to impede the normal function of Casq in vivo. Here, CASQ1 is linked to catecholaminergic polymorphic ventricular tachycardia.